BR0211049A - Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae - Google Patents
Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniaeInfo
- Publication number
- BR0211049A BR0211049A BR0211049-0A BR0211049A BR0211049A BR 0211049 A BR0211049 A BR 0211049A BR 0211049 A BR0211049 A BR 0211049A BR 0211049 A BR0211049 A BR 0211049A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- prevention
- treatment
- mycoplasma hyopneumoniae
- hyo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
"MéTODO DE TRATAMENTO OU PREVENçãO DE DOENçAS OU DISFUNçõES E USO DE MYCOPLASMA HYOPNEUMONIAE". A presente invenção refere-se ao tratamento ou prevenção de doenças ou disfunções em animais causadas pela infecção por Mycoplasma bovis (M. bovis) através da administração ao animal de quantidade eficaz de uma vacina de Mycoplasma hyopneumoniae (M. hyo). A vacina de M. hyo pode ser uma preparação viva inativada ou modificada de células inteiras ou parciais, uma vacina de subunidades ou uma vacina de DNA ou ácido nucléico. A vacina de M. hyo administrada de acordo com a presente invenção pode ser sintetizada ou produzida de forma recombinante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30258601P | 2001-07-02 | 2001-07-02 | |
PCT/IB2002/001937 WO2003004051A2 (en) | 2001-07-02 | 2002-05-30 | Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211049A true BR0211049A (pt) | 2004-07-20 |
Family
ID=23168382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211049-0A BR0211049A (pt) | 2001-07-02 | 2002-05-30 | Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae |
Country Status (9)
Country | Link |
---|---|
US (1) | US7056492B2 (pt) |
EP (1) | EP1521592A2 (pt) |
JP (1) | JP2004537543A (pt) |
CN (1) | CN1612749A (pt) |
AR (1) | AR034677A1 (pt) |
BR (1) | BR0211049A (pt) |
CA (1) | CA2452666A1 (pt) |
MX (1) | MXPA03011924A (pt) |
WO (1) | WO2003004051A2 (pt) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003017755A2 (en) * | 2001-08-28 | 2003-03-06 | Pfizer Products Inc. | Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions |
SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
WO2006056841A1 (en) * | 2004-11-24 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Multiple-strain mycoplasma hyopneumoniae vaccines |
US20110059437A1 (en) * | 2006-09-07 | 2011-03-10 | Boehringer Ingelheim Vetmedica, Inc. | Pcr-based genotyping |
AR069087A1 (es) | 2007-10-29 | 2009-12-30 | Boehringer Ingelheim Vetmed | Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma |
DK2217271T3 (en) * | 2007-11-06 | 2016-06-06 | Zoetis Services Llc | Avirulent, live vaccine with adjuvant against Mycoplasma hyopneumoniae |
US8444989B1 (en) * | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
WO2009156960A2 (en) | 2008-06-27 | 2009-12-30 | Pfizer Inc. | Novel adjuvant compositions |
US8815255B2 (en) * | 2008-10-31 | 2014-08-26 | Boehringer Ingelheim Vetmedica, Inc. | Use of Mycoplasma bovis antigen |
UY32570A (es) | 2009-04-24 | 2010-11-30 | Boehringer Ingelheim Vetmed | Vacuna viva modificada de mycoplasma bovis mejorada |
AU2010251761B2 (en) * | 2009-05-19 | 2014-10-09 | Bioproperties Pty Ltd | A temperature sensitive vaccine strain of Mycoplasma hyopneumoniae and uses thereof |
TWI583403B (zh) | 2009-06-04 | 2017-05-21 | 國立感染症研究所 | 黴漿菌感染症用疫苗 |
EP2654785B1 (en) * | 2010-12-22 | 2019-03-20 | Bayer Intellectual Property GmbH | Enhanced immune response in bovine species |
UA115053C2 (uk) * | 2012-03-07 | 2017-09-11 | Сева Санте Анімаль | Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти) |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
AU2013370983B2 (en) | 2012-12-28 | 2019-09-26 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
UA121097C2 (uk) * | 2012-12-28 | 2020-04-10 | Бьорінгер Інгельхайм Ветмедіка Гмбх | Імуногенна композиція, що містить антигени мікоплазм |
WO2015035474A1 (en) * | 2013-09-16 | 2015-03-19 | The University Of Melbourne | Serological test |
JP6586083B2 (ja) | 2013-09-19 | 2019-10-02 | ゾエティス・サービシーズ・エルエルシー | 油性アジュバント |
ES2714000T3 (es) | 2013-11-21 | 2019-05-24 | Agricultural Tech Res Inst | Composición para prevenir y curar una infección por micoplasma |
MX2016010993A (es) | 2014-02-28 | 2017-05-01 | Bayer Animal Health Gmbh | Plasmidos inmunoestimuladores. |
CN105012948B (zh) * | 2014-04-18 | 2019-07-30 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其应用 |
CN104248753B (zh) * | 2014-05-15 | 2017-07-28 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其应用 |
KR20170097116A (ko) | 2015-01-16 | 2017-08-25 | 조에티스 서비시즈 엘엘씨 | 구제역 백신 |
US10279031B2 (en) | 2016-05-11 | 2019-05-07 | Phibro Animal Health Corporation | Composition comprising antigens and a mucosal adjuvant and a method for using |
CN111856005B (zh) * | 2020-06-22 | 2021-07-30 | 华中农业大学 | 牛支原体分泌蛋白MbovP280的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT65827A (en) * | 1990-04-02 | 1994-07-28 | Synergen Inc | Polypeptides useful in animal treatment against mycoplasma infections |
US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
US5788962A (en) * | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
-
2002
- 2002-05-30 JP JP2003510061A patent/JP2004537543A/ja active Pending
- 2002-05-30 EP EP02733079A patent/EP1521592A2/en not_active Withdrawn
- 2002-05-30 CN CNA028134311A patent/CN1612749A/zh active Pending
- 2002-05-30 WO PCT/IB2002/001937 patent/WO2003004051A2/en active IP Right Grant
- 2002-05-30 CA CA002452666A patent/CA2452666A1/en not_active Abandoned
- 2002-05-30 MX MXPA03011924A patent/MXPA03011924A/es active IP Right Grant
- 2002-05-30 BR BR0211049-0A patent/BR0211049A/pt not_active IP Right Cessation
- 2002-06-20 US US10/177,860 patent/US7056492B2/en not_active Expired - Fee Related
- 2002-07-01 AR ARP020102478A patent/AR034677A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003004051A2 (en) | 2003-01-16 |
WO2003004051A3 (en) | 2005-02-17 |
CA2452666A1 (en) | 2003-01-16 |
US20030064079A1 (en) | 2003-04-03 |
AR034677A1 (es) | 2004-03-03 |
US7056492B2 (en) | 2006-06-06 |
JP2004537543A (ja) | 2004-12-16 |
MXPA03011924A (es) | 2004-03-26 |
CN1612749A (zh) | 2005-05-04 |
EP1521592A2 (en) | 2005-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0211049A (pt) | Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae | |
BR0210804A (pt) | Vacinação de dose única com mycoplásma hyopneumoniae | |
BR0210798A (pt) | vacinas de mycoplasma bovis e métodos de redução de pneumonia em animais | |
BRPI0010612B8 (pt) | vacinas | |
BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
BR9909483A (pt) | Derivados de proteìnas ligantes pneumococcal colina para vacinas | |
BR0111916A (pt) | Métodos e composição para vacinação oral | |
BR0315319A (pt) | Terapias e procedimentos dentais com toxina botulìnica | |
BR9611623A (pt) | Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética. | |
BR0110971A (pt) | Composições e métodos para tratamento de infecções das mucosas | |
BR0211563A (pt) | Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
RU2258501C2 (ru) | Способ применения этидия бромистого для лечения пироплазмоза лошадей | |
TH64472A (th) | การให้วัคซีนขนาดยาเดียวที่มี Mycoplasma Hyopneumoniae | |
RU2213573C2 (ru) | Способ профилактики паратифа телят | |
RU2230505C2 (ru) | Способ профилактики туберкулеза крупного рогатого скота | |
BR0002381A (pt) | Agente para aumentar a liberação de acetilcolina no cérebro | |
Santiago | Slow progress on HIV vaccines | |
JP2004262847A (ja) | ワクチン製剤 | |
Tarr, AF, O'Grady, JM & Jenkins | Rabies in South Africa: rabies and the private practioner | |
Coates | Keep your horse on its feet & feeding | |
RU2001124669A (ru) | Способ профилактики паратифа телят | |
BR0314668A (pt) | Utilização de excipientes para aumentar a captação de dna por células musculares de suìno | |
TH77235A (th) | วัคซีน Mycoplasma bovis และวิธีสำหรับการลดปอดบวมในสัตว์ | |
UA60829A (uk) | Спосіб лікування орнітозу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2060 DE 29/06/2010. |